- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03194243
Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District (PURPLE) (PURPLE)
Pathway and Urgent caRe of Dyspneic Patient at the Emergency Department in LorrainE District
This is an observational prospective multicenter study of patients admitted for acute dyspnea in an emergency department of the participating centers in the Lorraine district.
The primary objective is to assess the outcome of this population according to the cause of acute dyspnea as well as identify the predictors of this outcome, both overall and according to each acute dyspnea cause.
Study Overview
Status
Conditions
Detailed Description
This observational prospective multicenter study will be conducted using data from electronic medical records, acquired as part of usual care, in patients admitted for acute dyspnea in the emergency department. Clinical, treatment, laboratory and imaging data acquired during the hospitalization (in the emergency department and in the department that admitted the patients following the emergency department stay) will be collected.
Vital status will be recorded at 30 days and 1 year post-admission.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Tahar CHOUIHED, MD
- Phone Number: + 33 3 83 85 14 96
- Email: t.chouihed@chru-nancy.fr
Study Contact Backup
- Name: Nicolas GIRERD, MD,PhD
- Phone Number: + 33 3 83 15 74 96
- Email: n.girerd@chru-nancy.fr
Study Locations
-
-
Lorraine
-
Forbach, Lorraine, France, 57604
- Recruiting
- CH Marie-Madeleine FORBACH - Service des Urgences
-
Contact:
- Caroline HLADNIK, MD
-
Principal Investigator:
- Caroline HLADNIK, MD
-
Lunéville, Lorraine, France, 54 301
- Recruiting
- CH LUNEVILLE - Service des Urgences
-
Contact:
- Julie THISSE, MD
-
Principal Investigator:
- Julie THISSE, MD
-
Metz, Lorraine, France, 57085
- Recruiting
- CHR METZ-THIONVILLE- Hôpital de Mercy- Service des Urgences
-
Contact:
- Elies ANDRE, MD
-
Principal Investigator:
- Elies ANDRE, MD
-
Nancy, Lorraine, France, 54000
- Recruiting
- CHRU Nancy - Service des Urgences
-
Contact:
- Tahar CHOUIHED, MD
- Phone Number: +33 3 83 85 14 96
- Email: t.chouihed@chru-nancy.fr
-
Contact:
- Adrien BASSAND, MD
- Phone Number: + 33 3 83 85 14 96
- Email: a.bassand@chru-nancy.fr
-
Sub-Investigator:
- Adrien BASSAND, MD
-
Pont-à-Mousson, Lorraine, France, 54 701
- Recruiting
- CH PONT A MOUSSON- Service des Urgences
-
Contact:
- Alexandre GROSJEAN, MD
-
Principal Investigator:
- Alexandre GROSJEAN, MD
-
Remiremont, Lorraine, France, 88204
- Recruiting
- CH REMIREMONT - Service des Urgences
-
Contact:
- Marie BREFFA, MD
-
Principal Investigator:
- Marie BREFFA, MD
-
Saint-Dié-des-Vosges, Lorraine, France, 88100
- Recruiting
- CH SAINT-DIE-DES-VOSGES - Service des Urgences
-
Contact:
- Patrice THIRION, MD
-
Principal Investigator:
- Patrice THIRION, MD
-
Thionville, Lorraine, France, 57100
- Recruiting
- CHR METZ-THIONVILLE- Hôpital Bel-Air- Service des Urgences
-
Contact:
- Phillippe SATTONNET, MD
-
Principal Investigator:
- Phillippe SATTONNET, MD
-
Épinal, Lorraine, France, 88021
- Recruiting
- CH EPINAL - Service des Urgences
-
Contact:
- Céline HOMEL, MD
-
Principal Investigator:
- Céline HOMEL, MD
-
Sub-Investigator:
- Jean-Dominique RISSER, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Men or women > or = 18 years.
- Patients with acute dyspnea admitted for acute dyspnea in the emergency department.
- Patient informed.
Exclusion Criteria:
- Cardiorespiratory arrest.
- Patient having expressed his or her opposition.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients admitted for acute dyspnea
Patients admitted for acute dyspnea in the emergency department
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
All cause mortality
Time Frame: From emergency admission for acute dyspnea up until 1 year
|
From emergency admission for acute dyspnea up until 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Demographic data
Time Frame: through hospital stay, an average of 10 days
|
through hospital stay, an average of 10 days
|
|
Clinical data
Time Frame: through hospital stay, an average of 10 days
|
through hospital stay, an average of 10 days
|
|
Treatment data
Time Frame: through hospital stay, an average of 10 days
|
through hospital stay, an average of 10 days
|
|
Laboratory data
Time Frame: through hospital stay, an average of 10 days
|
through hospital stay, an average of 10 days
|
|
Imaging data
Time Frame: through hospital stay, an average of 10 days
|
through hospital stay, an average of 10 days
|
|
Duration of hospitalization
Time Frame: At final discharge, an average of 10 days after admission
|
including emergency stay and conventional hospitalization
|
At final discharge, an average of 10 days after admission
|
Initial diagnosis in the emergency department
Time Frame: At admission
|
At admission
|
|
Final diagnosis of the initial hospitalization stay
Time Frame: At final discharge, an average of 10 days after admission
|
At final discharge, an average of 10 days after admission
|
|
Brain Natriuretic Peptide
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Estimated glomerular function rate
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Estimated plasma volume
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Liver biological biomarkers
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Urea
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Use of non-invasive ventilation
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Time of use of non-invasive ventilation
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Use of diuretics
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Time of use of diuretics
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Use of nitrates
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Time of use of nitrates
Time Frame: Through hospital stay, an average of 10 days
|
Through hospital stay, an average of 10 days
|
|
Department type admitting the patient following emergency management
Time Frame: Through hospital stay, an average of 10 days
|
intensive care unit, cardiology, cardiac intensive care unit, other ...
|
Through hospital stay, an average of 10 days
|
All cause in-hospital mortality
Time Frame: At final discharge, an average of 10 days after admission
|
At final discharge, an average of 10 days after admission
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Tahar CHOUIHED, MD, Central Hospital, Nancy, France
- Principal Investigator: Nicolas GIRERD, MD,PhD, Central Hospital, Nancy, France
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-A01877-44
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Dyspnea
-
Centre Hospitalier Universitaire de BesanconUnknownAcute Heart Failure | Acute DyspneaFrance
-
Medical University of ViennaRecruitingEchocardiography | Acute DyspneaAustria
-
Intersection Medical, Inc.CompletedPulmonary Congestion | Dyspnea, | Acute Heart Failure SyndromeUnited States
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Strasbourg, France; University Hospital, Clermont-Ferrand and other collaboratorsUnknown
-
CHOUIHED TaharCentral Hospital, Nancy, FranceRecruitingAcute Disease | Dyspnea; CardiacFrance
-
Vanderbilt University Medical CenterWayne State UniversityRecruitingDyspnea | Acute Heart Failure | Dyspnea; CardiacUnited States
-
Tufts Medical CenterFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoActive, not recruitingDyspnea | Acute Respiratory Failure | Acute on Chronic Respiratory FailureItaly, United States
-
University of OxfordCompleted
-
ThermoFisher Scientific Brahms Biomarkers FranceCompletedPulmonary Embolism | Acute Heart Failure | Severe Dyspnea | CAPD | AE COPDFrance